Director
DIN: 08523660
Neelam Singh is currently associated with 4 companies in various capacities such as Director, Individual Promoter and Nominee. They serve as a Director at FAMN PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08523660.Neelam Singh is currently involved in 3 different roles. Their most recent position is with SANLIFOX (OPC) PRIVATE LIMITED as a Nominee. The first company Neelam Singh was appointed to as a director was FAMN PHARMA PRIVATE LIMITED. Neelam Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Neelam Singh is currently associated with 4 companies in various capacities such as Director, Individual Promoter and Nominee. They serve as a Director at FAMN PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08523660.Neelam Singh is currently involved in 3 different roles. Their most recent position is with SANLIFOX (OPC) PRIVATE LIMITED as a Nominee. The first company Neelam Singh was appointed to as a director was FAMN PHARMA PRIVATE LIMITED. Neelam Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
7
Female
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (4)
Current LLPs (0)
Past Companies (0)
1y 5m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| FAMN PHARMA PRIVATE LIMITED | Director | 30-Jul-2019 |
| FAMN PHARMA PRIVATE LIMITED | Individual Promoter | 30-Jul-2019 |
| ZESTOXY PHARMA PRIVATE LIMITED | Director | 17-Feb-2022 |
| ZESTOXY PHARMA PRIVATE LIMITED | Individual Promoter | 17-Feb-2022 |
| ZESTCARE PHARMA (OPC) PRIVATE LIMITED | Director | 09-Jun-2022 |
| ZESTCARE PHARMA (OPC) PRIVATE LIMITED | Individual Promoter | 09-Jun-2022 |
| SANLIFOX (OPC) PRIVATE LIMITED | Nominee | 11-Nov-2024 |